Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.

Int J Mol Sci · 2013 · PMC3645730 · PMID 23584023

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The mean concentration of lysoPC a C 20:4 demonstrated a decreasing trend from stage I to stage IV breast cancer patients (9.22 ± 3.62 μM for stage I, 8.64 ± 2.20 μM for stage II, 8.37 ± 3.20 μM for stage III and 7.87 ± 2.50 μM for stage IV).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.